All In Biotech

Drug Trial Radar · NCT02736409

An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)

A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)

Last checked: Nov 20, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 219 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

219

Actual

Start

Apr 1, 2016

Primary completion

Nov 12, 2019

Study completion Nov 12, 2019

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Apr 13, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 11 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, double- blind extension study of Oral Budesonide Suspension (OBS) in adults and adolescents (11 to 55 years of age, inclusive) with Eosinophilic Esophagitis (EoE) who have completed participation in the SHP621-301 induction study (NCT02605837). The primary objective is to evaluate the maintenance of efficacy of OBS over 36 weeks. Maintenance of efficacy will be measured by the peak eosinophilic count and Dysphagia Symptom Questionnaire (DSQ) score.

Conditions

  • Eosinophilic Esophagitis (EoE)

Interventions

  • Oral Budesonide Suspension (OBS)Drug

    OBS 2mg twice daily

  • PlaceboDrug

    Matching Placebo dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Who Had Relapse During the Entire Week 36 PeriodTime frame: Week 36

Locations

62 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital

    Birmingham, Alabama

  • Phoenix Childrens Hospital

    Phoenix, Arizona

  • Del Sol Research Management

    Tucson, Arizona

  • Adobe Clinical Research LLC

    Tucson, Arizona

  • Arkansas Gastroenterology

    North Little Rock, Arkansas

  • GW Research, Inc.

    Chula Vista, California

  • Rady Children's Hospital San Diego

    San Diego, California

  • Colorado Children's Hospital

    Aurora, Colorado

  • Asthma and Allergy Associates PC

    Colorado Springs, Colorado

  • Rocky Mountain Pediatric Gastroenterology

    Lone Tree, Colorado

  • Connecticut Clinical Research Foundation

    Bristol, Connecticut

  • Connecticut GI, PC - Research Division

    Farmington, Connecticut

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Nature Coast Clinical Research LLC

    Inverness, Florida

  • Arnold Palmer Hospital For Children

    Orlando, Florida

  • Children's Center for Digestive Health Care

    Atlanta, Georgia

  • Gastroenterology Associates of Central Georgia, LLC

    Macon, Georgia

  • Grand Teton Research Group, PLLC

    Idaho Falls, Idaho

  • Northwestern University

    Chicago, Illinois

  • University of Illinois College of Medicine at Peoria Pediatric Subspecialty Clinic

    Peoria, Illinois

  • Indiana University

    Indianapolis, Indiana

  • Aquiant Research

    New Albany, Indiana

  • Gastroenterology of Southern Indiana

    New Albany, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas

  • Gastroenterology Associates LLC

    Baton Rouge, Louisiana

  • Clinical Trials Management LLC

    Metairie, Louisiana

  • Louisiana Research Center LLC

    Shreveport, Louisiana

  • Clinical Trials of America LA LLC - PPDS

    West Monroe, Louisiana

  • Tufts Medical Center

    Boston, Massachusetts

  • Brigham and Womens Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Clinical Research Institute of Michigan

    Chesterfield, Michigan

  • Minnesota Gastroenterology PA

    Plymouth, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Bozeman Health Deaconess Hospital

    Bozeman, Montana

  • Long Island Gastrointestinal Research Group LLP

    Great Neck, New York

  • Mount Sinai Medical Center

    New York, New York

  • Asheville Gastroenterology Associates PA

    Asheville, North Carolina

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

Showing 40 of 62 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.